Holocene Advisors, LP Zoetis Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $40.1 Million - $53 Million	264,977 Added 73.04%	627,740 $124 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $52.5 Million - $60.6 Million	314,311 Added 648.71%	362,763 $63.1 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $7.8 Million - $9.02 Million	48,452 New	48,452 $8.34 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $13.7 Million - $16.9 Million	92,362 Added 20.66%	539,496 $80 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $69.7 Million - $89.5 Million	447,134 New	447,134 $76.9 Million

1,919

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $85.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.